Story

S&P Revises Universal Health Services Outlook to Positive on Leverage Projections

ENTHMSVIIDZHZH-TWJAKOHI
Aug 11, 20262 min read
S&P Revises Universal Health Services Outlook to Positive on Leverage Projections
Text size
Background

S&P Global Ratings has revised its outlook on Universal Health Services Inc. (NYSE:UHS) to positive from stable, signaling a potential credit rating upgrade if the hospital operator maintains its improved leverage metrics. The credit rating agency affirmed UHS's 'BB+' issuer credit rating.

Rationale for the Revision

The positive outlook reflects S&P's view that an upgrade is possible if UHS's operating performance and financial policy successfully keep leverage in the 2.0x to 3.0x range. The agency's decision is contingent on health policy risks not increasing beyond current expectations.

This improved outlook comes as UHS has significantly improved its profitability, with its adjusted EBITDA margin rising about 250 basis points to approximately 16% from a trough of 13.5% in 2023, according to S&P.

Debt Issuance and Strategic Funding

In a related action, S&P assigned a 'BBB-' issue-level rating to UHS's proposed senior notes. Proceeds from the new issuance are slated to refinance a $700 million senior note due in September 2026 and partially fund the company's $835 million acquisition of Talkspace.

Sample IUX Markets – In-articleAd

UHS plans to fund the remainder of the Talkspace purchase price using a recently issued $400 million delayed-draw term loan. S&P assigned a '2' recovery rating to the new notes, indicating an expectation for substantial recovery of 70% to 90% in the event of a payment default.

S&P's Financial Forecast

S&P projects that UHS's financial performance will moderate but remain strong enough to support its credit profile. The agency's key forecasts include:

  • Revenue Growth: A decline to 7% to 7.5% in 2026, down from 9.7% in 2025, partly due to lower Affordable Care Act (ACA) enrollment following the expiration of subsidies.
  • Profitability: Adjusted EBITDA margin is expected to dip by about 60 basis points to 15.5% in 2026.
  • Leverage: Despite plans for approximately $800 million in share repurchases this year, S&P expects the company's leverage to remain below 2.5x in both 2026 and 2027.
  • Cash Flow: Adjusted free operating cash flow to debt is forecast to improve to 17.7% in 2026 from 16.7% in 2025.

Read next

More on Stocks
Back to latest news

LATEST